LETTER
Tuning of Mitsunobu Couplings in Carbocyclic Nucleoside Synthesis
3147
General Procedure
(6) Agrofoglio, L. A.; Challand, S. R. Acyclic, Carbocyclic and
L-Nucleosides; Kluwer Academic Publishers: Dordrecht /
Boston / London, 1998.
(7) Marquez, V. E.; Ezzitouni, A.; Russ, P.; Siddiqui, M. A.;
Ford, H.; Feldman, R. J.; Mitsuja, H.; George, C.; Barchi, J.
J. J. Am. Chem. Soc. 1998, 120, 2780.
(8) Béres, J.; Sági, G.; Tömösközi, I.; Gruber, L.; Baitz-Gács,
E.; Ötvos, L.; De Clercq, E. J. Med. Chem. 1990, 33, 1353.
(9) (a) Borthwick, A. D.; Biggadike, K. Tetrahedron 1992, 48,
571. (b) Agrofoglio, L.; Suhas, E.; Farese, A.; Condom, R.;
Challand, S. R.; Earl, R. A.; Guedj, R. Tetrahedron 1994, 50,
10611. (c) Crimmins, M. T. Tetrahedron 1998, 54, 9229.
(10) (a) Ludek, O. R.; Meier, C. Synthesis 2003, 13, 2101.
(b) Ludek, O. R.; Balzarini, J.; Meier, C. Eur. J. Org. Chem.
2005, submitted
DIAD (545 mL, 2.80 mmol) was added slowly to a suspension of
PPh3 (787 mg, 3.00 mmol) in anhydrous THF (11 mL). The mixture
was stirred for 0.5 h at 0 °C. This preformed complex was slowly
added to a suspension of the N3-Bz-thymine 9 (506 mg, 2.2 mmol)
and alcohol 10 (1.00 mmol) in anhydrous THF (6.0 mL) at –40 °C
under nitrogen. The reaction was slowly warmed to r.t. and stirred
overnight. The solvent was removed from the reaction mixture and
a NaOH solution in MeOH (1%; 15 mL) was added and stirred over-
night at r.t. to cleave the N3-benzoyl protecting group. The solution
was neutralized by the addition of 1 M HCl and then concentrated.
The crude product was purified by silica gel chromatography
(hexanes–EtOAc, 1:2) to yield N1-products 11a–h and the O2-iso-
mers 12a–h as colorless solids. The product ratio was determined
by 1H NMR spectroscopy by integration of the H-1¢ protons.
(11) (a) Jenny, T. F.; Previsani, N.; Benner, S. A. Tetrahedron
Lett. 1991, 32, 7029. (b) Jenny, T. F.; Horlacher, J.;
Previsani, N.; Benner, S. A. Helv. Chim. Acta 1992, 75,
1944. (c) Bonnal, C.; Chavis, C.; Lucas, M. J. Chem. Soc.,
Perkin Trans. 1 1994, 1401. (d) Pérez-Pérez, M. J.;
Rozenski, J.; Busson, R.; Herdewijn, P. J. Org. Chem. 1995,
60, 1531. (e) Borthwick, A. D.; Crame, A. J.; Exall, A. M.;
Weingarten, G. G.; Mahmoudian, M. Tetrahedron Lett.
1995, 36, 6929. (f) Schmitt, L.; Caperelli, C. A. Nucleosides
Nucleotides 1997, 16, 2165. (g) Choo, H.; Chong, Y.; Chu,
C. K. Org. Lett. 2001, 3, 1471.
(12) Ludek, O. R.; Balzarini, J.; Krämer, T.; Meier, C. Synthesis
2005, submitted
(13) (a) Pearson, R. G.; Songstad, J. J. Am. Chem. Soc. 1967, 89,
1827. (b) Parr, R. G.; Pearson, R. G. J. Am. Chem. Soc. 1983,
105, 7512.
References
(1) Marquez, V. E. In Advances in antiviral drug design, Vol.
2; De Clercq, E., Ed.; JAI Press: Greenwich, 1996, 89–146.
(2) Vince, R.; Hua, M. J. Med. Chem. 1990, 33, 17.
(3) Daluge, S. M.; Martin, M. T.; Sickles, B. R.; Livingston, D.
A. Nucleosides, Nucleotides Nucleic Acids 2000, 19, 297.
(4) Bisacchi, G. S.; Chao, S. T.; Bachard, C.; Daris, J. P.;
Innaimo, S.; Jacobs, G. A.; Kocy, O.; Lapointe, P.; Martel,
A.; Merchant, Z.; Slusarchyk, W. A.; Sundeen, J. E.; Young,
M. G.; Colonno, R.; Zahler, R. Bioorg. Med. Chem. Lett.
1997, 7, 127.
(5) (a) Balzarini, J.; Baumgartner, H.; Bodenteich, M.; De
Clercq, E.; Griengl, H. Nucleosides Nucleotides 1989, 8,
855. (b) Wyatt, P. G.; Anslow, A. S.; Coomber, B. A.;
Cousins, R. P. C.; Evans, D. N.; Gilbert, V. S.; Humber, D.
C.; Paternoster, I. L.; Sollis, S. L.; Tapolczay, D. J.;
Weingarten, G. G. Nucleosides Nucleotides 1995, 14, 2039.
Synlett 2005, No. 20, 3145–3147 © Thieme Stuttgart · New York